LEXX Lexaria Bioscience Corp

$LEXX Yes. Healthcare and Biotech have been two of the top performers over the last 24 hrs.. 🚀 LEXX is in a great position here: - Big catalysts heading into EOY - Balance sheet fully funded - Massive short positions trapped to provide more fuel 🔥 $XBI $IBB $IYH $XLV

$LEXX we got news plus one of the smallest float, cash on hand, what not to like here. Should be going soon imo.

$LEXX Quick Update 🚨 1. Quiet Short Covering: Those repeated small 100-to-300 share buys ticking through the tape aren't random retail orders—they look like shorts slowly buying back shares to de-risk. Holding a short position into an unblinded human trial is high-risk, and this low-volume bids ladder suggests subtle accumulation. 2. Dosing On Schedule & Staggered Data: Dosing continues toward its mid-November target with zero operational delays. Per Lexaria’s historical execution, bioanalytical lab processing for Arms 1 and 2 will wrap up first—meaning top-line PK (C_{\max}, \text{AUC}) and GI tolerability metrics for those cohorts will likely drop before Arm 3 fully concludes ⏰ 3. Management Blackout Window: The lack of open-market insider buying is pure legal protocol. With material non-public information (MNPI) on Study #7 execution and active pharma MTA evaluations, corporate insiders are legally locked out of trading. $LLY $NVO $IYH $XBI #GLP1

$LEXX THEY HAVE/ARE MILKING THIS COW (RETAIL INVESTORS) TO FINANCIAL DEATH...PLANNED MONEY GRAB BY CHRIS CHRIS AND THE "RAT KILLER". I HOPE THEY GET WHAT THEY DESERVE...ACTUALLY WHAT WE THINK THEY DESERVE.

$LEXX This company has got to be one of the most poorly managed in existence. They crush us with dilution after dilution as soon as we have a glimmer of hope. Then the shorts come in and crush us to the point we need another reverse split. Then after we catch some momentum post split they fuck us again with warrant dilution. Is it no wonder investors avoid this turd? In July I had over 100k shares, now I have less than 7k. I’m down 87%, 68% in the last 3 months. And these fucking imbeciles are wondering why the stock is in the toilet? Look in the mirror management, this is entirely a shit sandwich of your own making.

$LEXX This should have NEVER slipped under $5. $9.5m in cash on hand for a 6.5m mkt cap?! I’ll take that bet 🤝

$LEXX I don t have some BS prediction for the pps.. But under $3.00 pps after two large RSs says retail investors r f d and mtg plus wainwright equals liars thieves and POS IMHO GLTA FOR ME A BIG BIG.MISTAKE

$LEXX I am selling for good, IMO the stock is cooked. As far as my DD, human study pushed back to fiscal Q4 (Dec-Feb) and IMO the big pharma deadline will be pushed further accordingly. Before that time, I believe they will keep on using the ATM and the S/P will keep on collapsing.

$LEXX is there any news on the release date of human study? I thought it should have been released by end of september, no?

$LEXX It seems that the market and the world does not give a $#%## about LEXX and its MGT - PPS $2.50 says more than MGT BS

$LEXX all you newbie, be careful. You’re fighting Short traders, investment bank called Wainwright, and most importantly, management

$LEXX Whether the U.S. Securities and Exchange Commission (SEC) should look into a sharp post-offering stock drop depends entirely on the presence of fraudulent disclosures, insider trading, or illegal market manipulation, rather than the price decline itself. While a severe drop from $12 to $2 immediately following a capital raise orchestrated by an underwriter like H.C. Wainwright & Co. destroys massive retail shareholder value, these aggressive dilution mechanics are typically legal, contractually documented corporate actions common in micro-cap biotechnology firms like Lexaria Bioscience Corp. (NASDAQ: LEXX). Christopher and Wainwright totally screwed retail investors.....Bunka was in on it also

$LEXX I have lost more than $400k in this stock... lesson lerned... this company is a scam for retailers stay away!

$LEXX lol, animal studies' results were due in early September, more than a month ago. If you can't keep up with such a short timeline, what will? IMO this is a stock for large investors than can short the stock on warrant raises, retail shareholders IMO better stay away, as this is poised to go lower and lower, R/S and repeat.

$LEXX I'm long lexx for the first time since selling at $10-$11. The main reason is that it's trading below cash value and we have seen some strong bounces off of the all time low. There was some decent volume today as well. Looking for $7.50-$10 exit by year end. How the catalysts ahead proves out.

$LEXX marks its 70th patent award, adding new US, Canadian and European patents for diabetes, hypertension and epilepsy treatments.

$LEXX dropping back to under $1 right on schedule. It’s deal or death for this stock and how many of us have confidence in management to get a deal done?

$LEXX IMO the stock is going slowly toward the sub 1 tp, with a R/S thereafter. I believe this is a rinse and repeat.

$LEXX why didn't you tag me? Are you a paid pumper? Do you feel stressed holding heavy bags of a stock that's in a perpetual downtrend? I didn't capitulate. I sold for a small % loss, protected capital, and proceeded to multiply it. Big difference in wording and truth. You're not understanding the point I'm trying to make here. Over a 75% crash in days is not necessary to make money. It's not a prerequisite. I made about 25x in PLTR and 28x in Moderna leap options by buying rock bottom and with full confidence that they weren't going crash 80% from the macro bottom. Even crypto large and mid caps will give those returns of 20x+ for buyers who successfully buy bear market bottoms. Lexaria's management is obviously abusing the investors and profiting from doing so at the same time. Then there's the huge price of opportunity cost. While holders continue to hold a stock rolling down a mountain, that money could have been used to invest in stocks that go up 3x, 5x, 10x, and more.

$LEXX Curiosity got the best of me. Nice news yesterday. A preamble to what to come. May hold this one till 2nd quarter 2027. Smaller but healthy starter well under $3.00. Several negatives, many positives as well. Love watching companies grow. NFA. Jmo. Trade for yourselves.